Molecular Imaging 2017

Clinical Trials of Novel Agents:

 Safety/Toxicity/Dosage Phase I

Phase II

Phase III

 Randomisation  Tested vs standard treatment

 Drug effectiveness  Safety

Question: Is the agent safe & is there biological activity?

Question: Does the drug work sufficiently well?

Question: How well does the drug work compared to what we have?

Go/No go

Go/No go

Targeted imaging